← Back to Search

Facebook Group for Tobacco Smoking (CAN Quit Trial)

N/A
Waitlist Available
Led By Christi A Patten, Ph.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Inclusion
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

This trial tests a Facebook-based program designed to help Alaska Native smokers quit by sharing relatable stories and tips. The goal is to provide a culturally relevant way to support smoking cessation in this high-risk group. The CAN Quit program is a Facebook-based intervention developed to promote smoking cessation among Alaska Native people by connecting them with culturally relevant resources and support.

Eligible Conditions
  • Tobacco Smoking
  • Smoking
  • Smoking Cessation
  • Tobacco Use
  • Smoking/Cigarette Smoking
  • Quitting Smoking

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biochemically Confirmed Abstinence From Smoking
Smoking Cessation Program Completion
Secondary outcome measures
Quit Attempts
Self-reported 7-day Point Prevalence Smoking Abstinence
Self-reported Use of Evidence-based Cessation Treatments

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Facebook+Quitline/Treatment ReferralExperimental Treatment1 Intervention
Participants join a secret/private, culturally relevant Facebook group moderated by an AN tobacco research counselor for 3 months Once daily moderator postings for 30 days, repeated each month for 3 months; plus 3-4 daily check-ins/postings to respond to participant generated content and encourage sharing of personal stories/experiences relevant to all stages of the quitting process and treatment engagement Description of tobacco treatment services, phone numbers and web links sent via postal mail (printed materials) and email. Treatment options provide free, professional assistance based on U.S. clinical practice guidelines: (1)AK quitline, (2)regional tribal tobacco cessation programs, and (3)smokefree.gov resources (e.g., free texting program and smartphone application, quit guide)
Group II: Quitline/Treatment ReferralActive Control1 Intervention
Description of tobacco treatment services, phone numbers and web links sent via postal mail (printed materials) and email. Treatment options provide free, professional assistance based on U.S. clinical practice guidelines: (1)AK quitline, (2)regional tribal tobacco cessation programs, and (3)smokefree.gov resources (e.g., free texting program and smartphone application, quit guide)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Facebook Group
2019
N/A
~190

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,255 Previous Clinical Trials
3,835,345 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,503 Previous Clinical Trials
2,625,522 Total Patients Enrolled
Christi A Patten, Ph.D.Principal InvestigatorMayo Clinic
1 Previous Clinical Trials
70 Total Patients Enrolled
~11 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top